Wnt receptor gene FZD1 was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohort

X Liu; SK Low; JR Atkins; JQ Wu; WR Reay; HM Cairns; MJ Green; U Schall; A Jablensky; B Mowry; PT Michie; SV Catts; F Henskens; C Pantelis; C Loughland; AV Boddy; PA Tooney; RJ Scott; VJ Carr; MJ Cairns

Journal article

Wnt receptor gene FZD1 was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohort

X Liu, SK Low, JR Atkins, JQ Wu, WR Reay, HM Cairns, MJ Green, U Schall, A Jablensky, B Mowry, PT Michie, SV Catts, F Henskens, C Pantelis, C Loughland, AV Boddy, PA Tooney, RJ Scott, VJ Carr, MJ Cairns

Australian and New Zealand Journal of Psychiatry | SAGE PUBLICATIONS LTD | Published : 2020

DOI: 10.1177/0004867419885443

Abstract

Objectives: Large-scale genetic analysis of common variation in schizophrenia has been a powerful approach to understanding this complex but highly heritable psychotic disorder. To further investigate loci, genes and pathways associated more specifically in the well-characterized Australian Schizophrenia Research Bank cohort, we applied genome-wide single-nucleotide polymorphism analysis in these three annotation categories. Methods: We performed a case–control genome-wide association study in 429 schizophrenia samples and 255 controls. Post-genome-wide association study analyses were then integrated with genomic annotations to explore the enrichment of variation at the gene and pathway leve..

View full abstract

University of Melbourne Researchers

Christos Pantelis Author

Related Projects (2)

RESEARCH FELLOWSHIP - PROF CHRISTOS PANTELIS

I have established and head the Melbourne Neuropsychiatry Centre within the University of Melbourne. My university position is a research ch..

NEUROBIOLOGICAL 'RISK' AND 'RESILIENCE' BIOMARKERS OF SEVERE MENTAL ILLNESS

Mental disorders of childhood (schizotypal disorder, autism spectrum disorders) and adolescence (psychoses, schizophrenia) represent a major..

Grants

Awarded by Sylvia and Charles Viertel Charitable Foundation

Funding Acknowledgements

The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: Data and samples were collected by the Australian Schizophrenia Research Bank (ASRB), supported by the Australian NHMRC, the Pratt Foundation, Ramsay Health Care and the Viertel Charitable Foundation. The ASRB was also supported by the Schizophrenia Research Institute (Australia), utilizing infrastructure funding from the NSW Health and the Macquarie Group Foundation. DNA analysis was supported by the Neurobehavioral Genetics Unit, utilizing funding from NSW Health. J.R.A. was supported by the University of Newcastle RHD and an Emlyn and Jennie Thomas Postgraduate Medical Research Scholarship. W.R.R. is supported by an Australian Postgraduate Award. C.L. was supported by National Health and Medical Research Council (NHMRC) Project Grants (1067137). M.J.C. was supported by an NHMRC Senior Research Fellowship (1121474). C.P. was supported by a NHMRC Senior Principal Research Fellowship (628386 & 1105825).